Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.

European journal of nuclear medicine and molecular imaging

Volumn 40, Issue 4, 2013, Pages 580-593

  Forsberg, Anton ^a   Juréus, Anders ^b   Cselényi, Zsolt ^b   Eriksdotter, Maria ^b   Freund Levi, Yvonne ^b   Jeppsson, Fredrik ^b   Swahn, Britt Marie ^b   Sandell, Johan ^b   Julin, Per ^b   Schou, Magnus ^b   Andersson, Jan ^b   Johnström, Peter ^b   Varnäs, Katarina ^b   Halldin, Christer ^b   Farde, Lars ^b   Svensson, Samuel ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (6 (METHYLAMINO)PYRIDIN 3 YL) 1,3 BENZOTHIAZOL 6 OL; 2-(6-(METHYLAMINO)PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-6-OL; AMINOPYRIDINE DERIVATIVE; AMYLOID BETA PROTEIN; AZD2995; BENZOTHIAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; CARBON; DIAGNOSTIC AGENT; N METHYL 2 (4' METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE; RADIOPHARMACEUTICAL AGENT;

AGED; ALZHEIMER DISEASE; ANIMAL; ARTICLE; BINDING SITE; BRAIN; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOASSAY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINOPYRIDINES; AMYLOID BETA-PEPTIDES; ANIMALS; BENZOTHIAZOLES; BENZOXAZOLES; BINDING SITES; BRAIN; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84882238957     PISSN: None     EISSN: 16197089     Source Type: None    
DOI: 10.1007/s00259-012-2322-6     Document Type: Article

References (0)